Team-based Financial Incentives for Smoking Cessation

Tobacco Use Disorder Clinical Trial

— StPaulKorea  

Official title:

The Effectiveness of Team-based Financial Incentives for Increasing Long-term Smoking Cessation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01323725
• Other study ID #: StPaulKorea
• Status: Completed
• Phase: N/A
• First received: March 25, 2011
• Last updated: May 2, 2016
• Start date: January 2011
• Est. completion date: December 2011

Study information

• Verified date: May 2016
• Source: St.Paul's Hospital, Korea
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to identify the effectiveness of team-base financial incentives for increasing long-term smoking cessation among employees at St. Paul's Hospital, Korea.

Description:

About 70% of smokers report that they want to quit, but annually 2 to 3% of smokers succeed. Smoking-cessation programs and pharmacologic therapies have been proven effective in helping smokers quit, but only a few smokers are enrolled in those programs.

Financial incentives may contribute to reinforce smoking cessation among workers through the following pathways: (1) increasing the number of tobacco users who participate in cessation effort; (2) increasing the number of tobacco user who initiate an attempt to quit; and (3) increasing the number of tobacco users who sustain a successful quit effort. Moreover, there is a number of advantages to offering smoking cessation support in the workplace, including the accessibility of the target population, the availability of occupational health support and the potential for peer pressure and peer support. In addition, team-based approach for smoking cessation could likely make use of new or existing cessation support resources offered within the workplace.

This study is a clinical trial of team-based financial incentives for smoking cessation among a sample of 60 smokers, who are health care workers from St. Paul's Hospital in Korea. Smokers will be given a usual care (counseling, education and coverage of prescription drugs) plus a package of financial incentives for self-reported and biochemically validated smoking cessation (urine or saliva cotinine). All incentives will be provided to each team at 6 months post-quit date.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 28
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Employees of St. Paul's Hospital at work sites in Korea

• Current smoker who report having smoked at least 5 cigarettes per day for the prior 12 months

• Age 18 or older

Exclusion Criteria:

• Age 17 or younger

• Unwilling to quit smoking

• Smoker who does not want to be enrolled in this trial

• Planning to leave St. Paul's hospital within the next 12 months

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Tobacco Use Disorder

Intervention

Behavioral:
• Team-based financial incentives
Team-based financial incentives for smoking cessation at 6 month post-quit date.

Locations

Country	Name	City	State
Korea, Republic of	St.Paul's Hospital	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
St.Paul's Hospital, Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Smoking Cessation Rate	Self-reported and biochemically validated smoking cessation rate at 6 months post-quit date	6 months	No
Secondary	Smoking Cessation Rate	Self-reported and biochemically validated smoking cessation rate at 3, 9, 12 months post-quit date	3, 9, 12 months	No